2010 (v1)
Publication
No description
Uploaded on: April 14, 2023
V
Last name: VREMIS L
No description
Longterm treatment with ET-1 receptor antagonist in combination with iloprost was found to interfere with progression of nailfold microvascular damage in patients with SSc, as assessed by NVC over a 3-year followup period.